Valuation: Cellnovo

Market Cap 2.44M 2.11M 1.99M 1.81M 3.39M 234M 3.41M 23.82M 9.2M 119M 9.15M 8.95M 378M P/E 2018 *
-0.15x
P/E 2019 * -
Enterprise Value 12.46M 10.8M 10.2M 9.26M 17.36M 1.2B 17.47M 122M 47.07M 606M 46.8M 45.76M 1.93B EV / Sales 2018
8.63x
EV / Sales 2019 * -
Free-Float
99.67%
Yield 2018 *
-
Yield 2019 * -
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 2.68M
-0.53%+3.81% - - 12.8B
-1.89%+7.72%-26.10%-37.55% 9.86B
-0.84%-4.94%-42.80%+101.46% 7.06B
-0.26%-0.36%-60.96%+117.42% 3.58B
-1.11%-2.91%-44.07%-11.58% 2.38B
+1.14%-3.52%-35.04%-29.22% 1.84B
+0.15%+4.40%+28.52%+86.61% 1.64B
+2.01%+3.09%+8.06%+67.88% 1.53B
+1.22%-3.72%-43.06%-37.09% 1.02B
Average +0.58%-0.35%-26.93%+32.24% 4.17B
Weighted average by Cap. +0.70%+0.90%-32.23%+30.91%

Financials

2018 2019 *
Net sales 3.32M 2.88M 2.72M 2.47M 4.63M 319M 4.66M 32.48M 12.55M 162M 12.48M 12.2M 515M -
Net income -15.94M -13.81M -13.06M -11.85M -22.21M -1.53B -22.35M -156M -60.22M -776M -59.87M -58.55M -2.47B -
Net Debt 10.02M 8.69M 8.21M 7.45M 13.97M 961M 14.05M 98M 37.87M 488M 37.65M 36.81M 1.55B -
Logo Cellnovo
Cellnovo Group SA is a France-based company principally engaged in medical instrument manufacturing . The Company specialized in the development of a mobile system for managing type 1 diabetes. Its apparatus includes a cordless micro-pump (a patch pump), an integrated monitoring device and a cellular handset with touch screen with an embedded blood glucose meter. The Company system enables diabetics to live a normal life whilst closely monitoring their glycaemia, their use of insulin, their activity and their food intake.
Employees
-
  1. Stock Market
  2. Stocks
  3. CLNV Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!